UK: IP Snapshot - January 2010

Last Updated: 18 January 2010
Article by Nick Beckett, Isabel Davies and Tom Scourfield

Bringing you monthly news of key developments in intellectual property law.


Sun Microsystems Inc v M-Tech Data Ltd and Stephen Lawrence Lichtenstein, High Court, 25 November 2009

Sun Microsystems won summary judgment in relation to parallel traded disk drives bearing its registered trade marks which had originated in China, Chile and the US and been placed on the European market by the Defendants without its consent. The Court rejected defences based on competition law. The decision is being appealed.

For the full text of the decision, click here (

Stella Kunststofftechnik GmbH v OHIM, EU General Court, 10 December 2009

The EU General Court (formerly the CFI) held that the existence of earlier opposition proceedings in relation to a CTM did not prevent the applicant from bringing revocation proceedings in respect of the CTM that was basis of the opposition. The General Court held that it was not apparent from the wording of Articles 50(1)(a) and 55(1)(a) that opposition proceedings brought on the basis of a mark that was still pending could influence the admissibility or the progress of revocation proceedings brought against that mark; opposition and revocation proceedings were two distinct and autonomous types of proceedings, each with their own effects, and it was possible for revocation proceedings to be brought even when opposition proceedings based on the mark to which the revocation proceedings relate have already been brought and are still pending.

For the full text of the decision, click here (

Trubion Pharmaceuticals Inc v OHIM, EU General Court, 15 December 2009

The EU General Court recently upheld the OHIM Board of Appeal's decision that there was a likelihood of confusion between the proposed word mark "TRUBION" and the existing "Tribion Harmonis" figurative mark for Class 5 goods.

The General Court shared the Board of Appeals's view that the word element "tribion" was the dominant part of the existing mark. It considered that the word "harmonis" was likely to be perceived only as a laudatory term and that the figurative element of the mark was fundamentally decorative in character. The Court held that, on an overall assessment, there was a certain amount of visual similarity between the marks and a very strong phonetic similarity. It concluded that, in view of the similarity between the goods in question and the marks at issue, there was a likelihood of confusion to the relevant public of end users and health professionals in the European Community.

Significantly, the General Court noted that manufacturers in the health sector (and in particular the sector of products complementing health products) very frequently market product lines within ranges bearing a particular word sign indicating the commercial origin of the goods followed by various word elements with an essentially descriptive function of the characteristics specific to that product range. In this context, the General Court considered that the term "tribion" is likely to be perceived by consumers as a sign indicating the origin of goods and "harmonis" as a laudatory term indicating a specific product within the "tribion" range.

For the full text of the decision, click here (

Bayer Healthcare LLC v OHIM, T-277/08, EU General Court, 11 Nov 2009

The EU General Court upheld the decision of the OHIM Board of Appeal that there was a likelihood of confusion under Article 8(1)(b) between the Spanish trade mark 'CICATRAL' and the proposed Community Trade Mark 'CITRACAL'. The goods (heating salves and dietary supplements) were found to be similar. In this regard the court compared the nature and function of each of the goods and found that the function of each of these goods was the same, namely the treatment of human health problems. The signs were also sufficiently similar given the high degree of visual and phonetic similarity. The court held there was no conceptual similarity as the words were imaginary with no conceptual content to take into account. There was therefore a likelihood of confusion on the part of the Spanish public.

For the full text of the decision, click here (

Torresan v OHIM, EU General Court, 19 November 2009

The EU General Court has upheld an OHIM Second Board of Appeal decision that the word mark CANNABIS is descriptive in respect of beer and other alcoholic beverages (classes 32 and 33), and thus invalid under Article 7(1)(c) of Regulation No 40/94 as a registered Community trade mark in respect of these classes of goods.

For the full text of the decision, click here (

Andreas Stihl AG & Co. KG, OHIM, 30 November 2009

The OHIM Fourth Board of Appeal held that an International Registration for a colour combination trade mark for power tools in class 7 is protected in the European Community on the basis of acquired distinctiveness, thereby partially allowing an appeal from an examiner's decision rejecting such protection. Although the appeal board confirmed that the examiner had been correct in deciding that the colour mark was not in itself distinctive under Article 7(1)(b) of CTM Regulation (EC) No. 207/2009, it held that the mark had acquired a distinctive character under Article 7(3) of the CTM Regulation through the widespread use that had been made of it.
The board of appeal took into account the evidence supplied by the applicant, which included several market surveys. The evidence showed that the applicant was in fact the market leader for the power tools in question and was recognised by a specialist public, which recognised the colour combination.

For the full text of the decision, click here (


Lucasfilm Ltd and others v Andrew Ainsworth and another, Court of Appeal, 16 December 2009

In July 2008, Mr Justice Mann found in part against Lucasfilm and its co-claimants, the production and licensing companies behind the original Star Wars films, in a complex and multi-jurisdictional copyright action brought against the defendant, Mr. Ainsworth, for the production of replica Star Wars "Stormtrooper" uniforms. Lucasfilm had brought claims for copyright, passing off and reverse passing off, breach of confidence, to ownership of any copyrights Mr Ainsworth might have created during the course of his activities, to enforce a US judgment previously obtained by it against Mr Ainsworth, and to enforce its US copyright directly in the English courts. Mann J found against Lucasfilm on all but its claim to enforce its US copyright directly in the UK, and its claim to entitlement to any copyrights owned by Mr Ainsworth. Both parties appealed.

The Court of Appeal has now upheld Mann J's decision on every point other than his finding that Lucasfilm could enforce their US copyrights directly in the English courts. The Court of Appeal held that the Brussels Regulation does not give rise to an international jurisdiction over copyright infringement claims, and that there were sound policy reasons for this.

For the full text of the decision, click here (


Leo Pharma v Sandoz, Court of Appeal, 11 November 2009

The Court of Appeal rejected Sandoz Limited's appeal against Floyd J's decision in the High Court that Leo Pharma's EP Patent (UK) was valid. The case provides a timely reminder of the role of the Court of Appeal and that an appellant in a patent case must show that the High Court judge 'erred in principle'.

For the full text of the decision, click here (

Gemstar-TV Guide International Inc. and others v Virgin Media Limited and other, High Court, 26 November 2009

Virgin Media has successfully defended a patent infringement claim brought against it by Gemstar TV Guide International Inc (Gemstar). Gemstar claimed Virgin Media infringed three of its patents relating to EPGs: the "Single Channel Patent", the "Favourites Patent" and the "Transfer Patent". Virgin Media denied the infringement and sought the revocation of the patents.

Justice Mann held that two of the patents were found to be unpatentable due to lack of a technical contribution and were therefore excluded from patentability. In addition, the patents in dispute were invalid for lack of novelty or inventive step and as a result, even if they were not excluded from patentability, were not infringed.

For the full text of our Law-Now update on this decision, click here (

Ian Alexander Shanks v Unilever plc and others, High Court, 3 December 2009

The High Court has held that the wording of section 41(2) of the Patents Act 1977, dealing with compensation to employee inventors in cases where the invention had been transferred to a company connected to the employer, could not be interpreted literally as such an interpretation could produce absurd results clearly inconsistent with the intentions of Parliament. Such transfers should be treated as being to a non-connected, arm's-length person operating in the appropriate market at the appropriate time.

For the full text of the decision, click here (

Dr Reddy's Laboratories (UK) Limited v Eli Lilly Company Limited [2009] EWCA Civ 1362, 18 December 2009

The Court of Appeal has dismissed an appeal against a decision by the High Court that a patent for a drug used to treat schizophrenia was valid. The Court of Appeal agreed with Floyd J, the High Court judge, that the claimed compound was not invalidated as being anticipated by, or obvious in light of, a previous patent application which disclosed a huge general class of compounds, even though the patented compound was one of that class. The Court of Appeal followed the approach of the EPO to selection patents preferring its approach to the approach in pre-1977 Patents Act case law; in doing so, the Court of Appeal followed the trend of recent years.

For the full text of the decision, click here (

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 15/01/2010.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.